Financial results - NATALMED DR. CHIRLA SRL

Financial Summary - Natalmed Dr. Chirla Srl
Unique identification code: 35690523
Registration number: J02/278/2016
Nace: 8622
Sales - Ron
77.370
Net Profit - Ron
19.807
Employee
3
The most important financial indicators for the company Natalmed Dr. Chirla Srl - Unique Identification Number 35690523: sales in 2023 was 77.370 euro, registering a net profit of 19.807 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Natalmed Dr. Chirla Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - 4.146 10.981 46.302 57.461 78.102 77.370
Total Income - EUR - - - - 4.146 11.166 46.302 57.461 78.508 77.370
Total Expenses - EUR - - - - 2.273 8.874 13.061 13.199 33.172 56.789
Gross Profit/Loss - EUR - - - - 1.873 2.291 33.242 44.262 45.336 20.581
Net Profit/Loss - EUR - - - - 1.755 1.961 32.693 43.687 44.555 19.807
Employees - - - - 0 0 0 0 4 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -0.6%, from 78.102 euro in the year 2022, to 77.370 euro in 2023. The Net Profit decreased by -24.613 euro, from 44.555 euro in 2022, to 19.807 in the last year.

Check the financial reports for the company - Natalmed Dr. Chirla Srl

Rating financiar

Financial Rating -
Natalmed Dr. Chirla Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Natalmed Dr. Chirla Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Natalmed Dr. Chirla Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Natalmed Dr. Chirla Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Natalmed Dr. Chirla Srl - CUI 35690523

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - 1.834 1.538 1.806 1.268 34.630 29.639
Current Assets - - - - 7.070 7.525 42.347 86.169 32.326 57.331
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 0 0 0 0 0 0
Cash - - - - 7.070 7.525 42.347 86.169 32.326 57.331
Shareholders Funds - - - - 6.959 8.786 41.312 84.084 64.864 84.474
Social Capital - - - - 43 42 41 40 41 40
Debts - - - - 1.945 277 2.842 3.353 2.092 2.496
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 57.331 euro in 2023 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 57.331 euro.
The company's Equity was valued at 84.474 euro, while total Liabilities amounted to 2.496 euro. Equity increased by 19.807 euro, from 64.864 euro in 2022, to 84.474 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Natalmed Dr. Chirla Srl

Comments - Natalmed Dr. Chirla Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.